Trupanion, Inc. (NASDAQ:TRUP) insider Darryl Rawlings sold 3,500 shares of the business’s stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $34.08, for a total value of $119,280.00. Following the completion of the sale, the insider now directly owns 1,386,476 shares in the company, valued at approximately $47,251,102.08. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Darryl Rawlings also recently made the following trade(s):
- On Wednesday, December 27th, Darryl Rawlings sold 3,500 shares of Trupanion stock. The stock was sold at an average price of $30.11, for a total value of $105,385.00.
- On Wednesday, December 13th, Darryl Rawlings sold 3,500 shares of Trupanion stock. The stock was sold at an average price of $30.10, for a total value of $105,350.00.
Trupanion, Inc. (TRUP) opened at $33.76 on Friday. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $1,014.15, a price-to-earnings ratio of -375.07 and a beta of 0.14. Trupanion, Inc. has a 1-year low of $13.88 and a 1-year high of $35.07.
Hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. purchased a new position in shares of Trupanion during the third quarter valued at $143,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Trupanion during the third quarter valued at $221,000. Voya Investment Management LLC purchased a new position in shares of Trupanion during the second quarter valued at $215,000. Wells Fargo & Company MN grew its holdings in shares of Trupanion by 13.5% during the second quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock valued at $252,000 after buying an additional 1,342 shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. purchased a new position in shares of Trupanion during the third quarter valued at $325,000. Institutional investors and hedge funds own 63.25% of the company’s stock.
A number of equities analysts recently issued reports on the company. CL King assumed coverage on Trupanion in a report on Tuesday, November 21st. They issued a “neutral” rating on the stock. BidaskClub cut Trupanion from a “hold” rating to a “sell” rating in a report on Tuesday, December 5th. Zacks Investment Research upgraded Trupanion from a “hold” rating to a “buy” rating and set a $37.00 target price on the stock in a report on Wednesday, November 8th. Finally, Canaccord Genuity restated a “buy” rating and issued a $35.00 target price (up from $29.00) on shares of Trupanion in a report on Tuesday, October 31st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $28.83.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3148914/darryl-rawlings-sells-3500-shares-of-trupanion-inc-trup-stock.html.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.